Hospira announced it is recalling “more than 60 lots of the pain reliever ketorolac tromethamine injection in the U.S. and Singapore.” The recall was instigated by a “complaint of particulate,” specifically in this case, “visible, floating particulate identified in glass fliptop vials,” according to the FDA.
http://www.fiercepharmamanufacturing.com/story/hospira-recalls-60-lots-pain-drug/2015-02-12
No comments:
Post a Comment